Search

Your search keyword '"Gandemer, Virginie"' showing total 931 results

Search Constraints

Start Over You searched for: Author "Gandemer, Virginie" Remove constraint Author: "Gandemer, Virginie"
931 results on '"Gandemer, Virginie"'

Search Results

1. Impact of childhood leukemia on siblings: their long-term perception of family functioning and its relationship with their psychosocial characteristics using structural equation modeling

2. A software tool to support follow-up care in a French childhood cancer cohort: construction and feasibility

4. NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients

5. Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials

6. Recent results of hematopoietic stem cell transplantation for thalassemia with busulfan-based conditioning regimen in France: improved thalassemia free survival despite frequent mixed chimerism. A retrospective study from the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

7. Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group

8. Rôle de l’infirmière en pratique avancée (IPA) dans une unité de thérapie cellulaire : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

9. Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads

10. Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

11. Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

13. Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trial

14. Que retenir dans la prise en charge des cancers en 2022 ?

17. Conséquences d’un cancer dans l’enfance dans la quête du premier emploi dans l’interrégion Grand Ouest. Étude multiméthodes du groupe Grand Ouest Cancer de l’Enfant (GOCE) chez d’anciens patients et des professionnels

19. ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression: one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis

20. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study

21. DESCAR-T, le registre national des patients traités par CAR-T Cells

23. Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party

25. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study

26. COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)

27. Que retenir de l’année 2020 ?

28. Therapeutic drug monitoring of imatinib:how far are we in the leukemia setting?

29. Testosterone deficiency in men surviving childhood acute leukemia after treatment with hematopoietic stem cell transplantation or testicular radiation: an L.E.A. study

30. Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party

31. Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?

33. Environmental exposures related to parental habits in the perinatal period and the risk of Wilms' tumor in children

34. COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)

35. A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire

37. Treatment Duration and Complete Response (CR) in Adult and Pediatric Patients (Pts) Treated with Defibrotide (DF) for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Cell Transplantation (HCT) in the Defifrance and EBMT PASS Registries

38. IMPACT de la déprivation sociale sur les difficultés psychosociales au décours d’un cancer pédiatrique : une étude prospective

39. Qu’est-ce que 2023 aura permis de changer dans nos pratiques en cancérologie ?

40. Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins

41. Ovarian Function and Spontaneous Pregnancy After Hematopoietic Stem Cell Transplantation for Leukemia Before Puberty: An L.E.A. Cohort Study

43. Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL

44. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia

46. Adolescence and Socioeconomic Factors: Key Factors in the Long-Term Impact of Leukemia on Scholastic Performance—A LEA Study

47. IMPACT of the Social Deprivation on Psychosocial Difficulties of Pediatric Cancer Survivors: A Prospective Study.

48. Interest of Cytoreductive Therapy before Allogenic Hematopoietic Stem Cell Transplantation in Childhood Myelodysplastic Syndromes: A Retrospective Study on Behalf of the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

49. Unrelated Cord Blood Transplantation in Children, Adolescents, and Young Adults with Acute Leukemia or Myelodysplastic Syndrome: A Retrospective Comparative Study from the French Society for Bone Marrow Transplantation and Cellular Therapy Between Real-World Data and Previously Reported Results of a Randomized Clinical Trial

50. Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial

Catalog

Books, media, physical & digital resources